Remove 2024 Remove DEA Remove Legalization Remove Treatment
article thumbnail

The Week in Weed: December 22, 2023

The Blunt Truth

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. UNITED STATES ATTORNEYS Attorney General Merrick Garland and DEA Administrator Anne Milgram received a letter this week from several former United States Attorneys. Look for more on this in 2024 also.

DEA 52
article thumbnail

Lisa’s List: Industry News Update – August 2022

Cannabis Law Report

Government Agencies seek funding to research cannabinoids as treatments for various conditions: [link]. Delta 8 now legal in Kentucky: [link]. Virginia 2024 adult use program may be postponed: [link]. Columbia considering legalizing cannabis: [link]. Cannabinoids. Does Delta 8 show up on a drug test? [link].

DEA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to access and assess ketamine therapy options

The Cannigma

While costs to access ketamine therapy can be high in some locations, and like any drug ketamine is not a cure-all, some patients and their doctors have been reporting life-changing results when no other treatment provided relief. Patients may want to seek assistance from a certified professional prior to embarking on treatment.

Therapy 78
article thumbnail

Understanding the Current Legal Status of Psychedelics in the United States

Cannabis Law Report

The short answer is: that current legal options (i.e. legal at the state level or the state and federal level) are limited. Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression. Federal Legal Status.

article thumbnail

Publicly Traded Cannabis Company Plans $500M (!) EB-5 Raise (!!)

Canna Law Blog

Drug Enforcement Administration (“DEA”), the agency tasked with enforcing the CSA. In principal at least, if the EB-5 cannabis investment is solely supplying cannabis to approved, licensed researchers pursuant to preexisting DEA approval then that is not “trafficking in an illicit substance” under the INA.

DEA 69
article thumbnail

The Week in Weed: October 4, 2019

The Blunt Truth

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. Could it be the next state to legalize? Plus, a new bill would legalize cannabis with state-run stores. In Arizona , supporters of legalization have changed their ballot initiative language.

article thumbnail

The Week in Weed: October 25, 2019

The Blunt Truth

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. The 2019 edition of the Hemp and CBD Industry Factbook released figures that show retail sales of CBD topping $1 billion this year, and predicted that number could hit $10 billion by 2024.

Hemp 58